Molecular Mechanism Underlying Delivery of Platinum Agents to the Cancer and Kidney

Drug Delivery System - Japan
doi 10.2745/dds.27.381
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society of Drug Delivery System

Related search

Molecular Mechanism Underlying His-To-Asp Phosphorelay

Seibutsu Butsuri
2000English

Elucidation of the Molecular Mechanism Underlying Lymph Node Metastasis in Prostate Cancer

2006English

Insights Into the Molecular Mechanism Underlying Polymorph Selection

English

Structural Basis and Molecular Mechanism Underlying P2X7 Receptor Antagonism

Biophysical Journal
Biophysics
2017English

Molecular Characterization of Kidney Cancer

Cancer
Cancer ResearchOncology
2011English

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Chemical Reviews
Chemistry
2016English

Molecular Diagnosis and Therapy of Kidney Cancer

Annual Review of Medicine
BiochemistryMedicineGeneticsMolecular Biology
2010English

Molecular Basis of Chemosensitivity of Platinum Pre-Treated Ovarian Cancer to Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2010English

Mechanism of the Membrane Interaction of Polynuclear Platinum Anticancer Agents. Implications for Cellular Uptake

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy